Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I see your point. When it comes to scarring and f

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154409
(Total Views: 482)
Posted On: 05/26/2022 6:48:37 AM
Posted By: MGK_2
Re: ohm20 #123770
I see your point.
When it comes to scarring and fibrosis, I would tend to think the blood supply to those tissues is minimal if not non-existent. Therefore, any increase at least by diffusion to the surrounding encapsulating wall by sheer volume might show promise.

Secondly, in the NASH conference where Mazen Noureddin, MD, Cedars-Sinai Medical Center, they were discussing the non linear benefits of weight loss.

One statement made:
Quote:
"Modest 5% weight loss is associated with both cardiometabolic benefit and reversal of steatosis."
"Greater weight loss often associated with reversal of steatohepatitis (usually with weight loss >7% or fibrosis (usually with weight loss of > 10%).



So what this is suggesting is that just modest changes in weight loss, going from 5% to 7% has changes which may correlate going from a NAS of 3 to a NAS of 1 for 5% weight loss; and going from a NAS of 4 or 5 to a NAS of 1 or 2 for 7% weight loss. Lastly, fibrosis is associated with a NAS of 8 a patient would only need to lose 10% weight to begin losing fibrous tissue. NAS 8 >> NAS 5 with 10% weight loss.

That's why I am so bullish on doubling LL from 350 to 700mg. I think those cells which produce the fibrous scar tissue may be harder to access than the hepatocytes which produce fat.


(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us